Rothschild Investment LLC’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,074
Closed -$414K 3631
2025
Q4
$414K Buy
4,074
+187
+5% +$15K 0.02% 414
2025
Q3
$213K Buy
3,887
+2,774
+249% +$139K 0.01% 586
2025
Q2
$59.1K Buy
1,113
+13
+1% +$660 ﹤0.01% 745
2025
Q1
$47.6K Sell
1,100
-3
-0.3% -$152 ﹤0.01% 779
2024
Q4
$62K Sell
1,103
-2
-0.2% -$124 ﹤0.01% 741
2024
Q3
$75.3K Buy
1,105
+5
+0.5% +$282 ﹤0.01% 712
2024
Q2
$46.5K Hold
1,100
﹤0.01% 760
2024
Q1
$76K Hold
1,100
0.01% 649
2023
Q4
$81.4K Buy
+1,100
New +$72.1K 0.01% 574

Other funds holding EXAS

Rothschild Investment LLC's EXAS Position: Q1 2026 in Review

Rothschild Investment LLC sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,074 shares — an estimated $414K sold.

Rothschild Investment LLC first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $414K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Rothschild Investment LLC reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 4,074 Exact Sciences shares in Q1 2026, an estimated $414K.
  • Rothschild Investment LLC first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
  • Rothschild Investment LLC's Exact Sciences position peaked at $414K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.